E. I. Korotkevich, A. V. Rudik, A. V. Dmitriev, A. A. Lagunin, D. A. Filimonov
{"title":"Prediction of Metabolic Stability of Xenobiotics by the Pass and Gusar Programs","authors":"E. I. Korotkevich, A. V. Rudik, A. V. Dmitriev, A. A. Lagunin, D. A. Filimonov","doi":"10.1134/S1990750821040089","DOIUrl":null,"url":null,"abstract":"<p>Metabolic stability determines the susceptibility of compounds to biotransformation on the body. It is characterized by such parameters as half-life (<i>T</i><sub>1/2</sub>) and clearance (CL). In vitro systems based on cells or subcellular fractions (mainly liver microsomal enzymes) are consider as models of processes occurring in a living organism and are used for metabolic stability assessment. The data obtained from the experiments are used to build QSAR models. Based on the freely available database ChEMBL v.27, we collected more than 8000 records containing the structures of compounds and their clearance and/or half-life time values obtained on human liver microsomes. GUSAR (General Unrestricted Structure-Activity Relationships) and PASS (Prediction of Activity Spectra for Substances) software were used to create quantitative and qualitative models based on the collected data. A 5-fold cross-validation procedure was used to the model assessments. Thresholds <i>T</i><sub>1/2</sub> = 30 min and CL = 20 mL/min/kg were chosen to distinguish between stable and unstable molecules. The accuracy of the models changes from 0.5 (calculated using 5-fold cross-validation on quantitative models for predicting the half-life) to 0.96 (calculated using 5-fold cross-validation on classification models for predicting the clearance).</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"15 4","pages":"301 - 305"},"PeriodicalIF":0.6000,"publicationDate":"2021-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","FirstCategoryId":"2","ListUrlMain":"https://link.springer.com/article/10.1134/S1990750821040089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Metabolic stability determines the susceptibility of compounds to biotransformation on the body. It is characterized by such parameters as half-life (T1/2) and clearance (CL). In vitro systems based on cells or subcellular fractions (mainly liver microsomal enzymes) are consider as models of processes occurring in a living organism and are used for metabolic stability assessment. The data obtained from the experiments are used to build QSAR models. Based on the freely available database ChEMBL v.27, we collected more than 8000 records containing the structures of compounds and their clearance and/or half-life time values obtained on human liver microsomes. GUSAR (General Unrestricted Structure-Activity Relationships) and PASS (Prediction of Activity Spectra for Substances) software were used to create quantitative and qualitative models based on the collected data. A 5-fold cross-validation procedure was used to the model assessments. Thresholds T1/2 = 30 min and CL = 20 mL/min/kg were chosen to distinguish between stable and unstable molecules. The accuracy of the models changes from 0.5 (calculated using 5-fold cross-validation on quantitative models for predicting the half-life) to 0.96 (calculated using 5-fold cross-validation on classification models for predicting the clearance).
期刊介绍:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.